Brief: Cleveland Biolabs Reports Qtrly Loss Per Share $0.10
March 6 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS INC - QTRLY LOSS PER SHARE $0.10
* CLEVELAND BIOLABS-ESTIMATES CASH,CASH
EQUIVALENTS,SHORT-TERM
INVESTMENTS AS OF DEC 31 ENOUGH TO FUND OPERATIONS FOR AT LEAST
1 YEAR AFTER 10-K FILING DATE
Source text: (http://bit.ly/2FXHEdA)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc